(Q27131040)
English
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc
chemical compound
- H. pylori P466 LPS O-antigen
- alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc
- alpha-L-fucosyl-(1->3)-[alpha-L-fucosyl-(1->3)-[alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)]-N-acetyl-beta-D-glucosamine
- alpha-L-Fuc-(1->3)-[alpha-L-Fuc-(1->3)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)]-beta-D-GlcNAc
- (Gal)2 (GlcNAc)2 (LFuc)3
- alpha-L-Fuc-(1->2)-[3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->]2
- Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta
- Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb
Statements
1,186.448683±0 dalton
1 reference
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
C₄₆H₇₈N₂O₃₃
1 reference
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)C)O)O)O)OC7C(C(C(C(O7)C)O)O)O)NC(=O)C)O)CO)O)NC(=O)C)O)O)O
1 reference
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O[C@H]6[C@H]([C@@H]([C@@H]([C@@H](O6)C)O)O)O)O[C@H]7[C@H]([C@@H]([C@@H]([C@@H](O7)C)O)O)O)NC(=O)C)O)CO)O)NC(=O)C)O)O)O
1 reference
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
Identifiers
1 reference
2 references
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
1 reference
alpha-L-Fucp-(1->2)-[3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->]2 (English)
7 October 2016
2 references
(Gal)2 (GlcNAc)2 (LFuc)3 (English)
7 October 2016
2 references